Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 4

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1Head & Neck 1

Conditions

Oropharyngeal Neoplasms 1Multiple Myeloma 1Lymphoma 1Cognitive Dysfunction 1Adolescent and Young Adult Cancer Patient 1

Interventions

pembrolizumab 302Carboplatin 155Nivolumab 154Cisplatin 139Cyclophosphamide 130Paclitaxel 127Magnetic Resonance Spectroscopy 98Specimen Handling 95Radiotherapy 90Gemcitabine 87Dexamethasone 83Biopsy 81Ipilimumab 78Docetaxel 75Doxorubicin 75Rituximab 69Etoposide 67atezolizumab 61durvalumab 60Lenalidomide 59Radiation 59Pemetrexed 58Taxes 57Bevacizumab 54Prednisone 54fludarabine 54olaparib 53Cytarabine 49Vincristine 49Fluorouracil 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has results × Palliative Care × 1 year × Clear all
NCT05593016 2025-11-03

Adolescents and Young Adults (AYAs) With Advanced Cancer

Duke University

Phase NA Completed
75 enrolled 25 charts

Adolescent and Young Adult Cancer Patient

NCT06063603 2025-09-18

ASCENT

Mayo Clinic

Phase NA Completed
51 enrolled 8 charts
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT04952922 2025-08-08

FUNQOLR

Royal Marsden NHS Foundation Trust

Completed
25 enrolled 8 charts
Head & Neck

Oropharyngeal Neoplasms

NCT04669301 2025-07-15

Memory and Attention Adaptation Training-Geriatrics (MAAT-G) Phase II

University of Rochester

Phase NA Completed
72 enrolled 15 charts

Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡